DAND5 as a regulator of differentiation and mature readiness of PSC-CMS

Read full text Summarise with VIRAT
Authors: Micael Almeida
Cited by: 0
References: 120

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Cardiovascular disease (CVD) remains the leading cause of death globally, with myocardial infarction (MI) being a major contributor. The current therapeutic approaches are limited in effectively regenerating damaged cardiac tissue. Current strategies for heart regeneration/reconstitution aim at cardiac remodeling through repairing the damaged tissue with an external cell source or by stimulating the existing cells to proliferate and repopulate the compromised area. Cell reprogramming addresses this challenge and offers a promising solution, converting fibroblasts and other cell types into functional cardiomyocytes (CMs), either by reverting cells to a pluripotent state or by directly switching cell lineage. Several strategies, such as gene editing and the application of microRNAs and small molecules, have been explored for their potential to enhance cardiac regeneration. Those strategies take advantage of cell plasticity by introducing reprogramming factors that regress cell maturity in vitro, allowing for their later differentiation and thus endorsing cell transplantation, or promote in situ cell proliferation, leveraged by scaffolds embedded with pro-regenerative factors promoting efficient heart restoration. Despite notable advancements, important challenges persist, including low reprogramming efficiency, limitations in cell maturation, and safety concerns in clinical applications. Notably, modulation of DAND5 expression has shown potential in addressing some of these limitations. Reduced DAND5 levels have been associated with increased CM proliferation and a higher yield of cardiovascular progenitors, while also prolonging their progenitor state. Through DAND5 modulation, it is possible to enhance human induced pluripotent stem cells-derived CMs (hiPSC-CMs) generation and proliferation efficiency and later promote physiological maturation towards metabolic transition from glucose to fatty acids. This study explored the role of recently characterized regulatory genes associated with DAND5 in cardiogenesis, as well as the maturation potential of our DAND5-KO hiPSC-CMs. Integrating these innovative approaches offers a promising alternative for restoring cardiac function and reducing the dependency on full heart transplants.

Fields of Study & Subjects

Pluripotent Stem Cells Research Congenital heart defects research Mesenchymal stem cell research

Publication details

Journal / source
Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Publication date
17 March 2026
Language
EN
Document type
Thesis